These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17244202)

  • 1. Intravitreal VEGF-inhibitors: is Avastin a generic substitute for Lucentis?
    la Cour M
    Acta Ophthalmol Scand; 2007 Feb; 85(1):2-4. PubMed ID: 17244202
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravitreal avastin: the low cost alternative to lucentis?
    Rosenfeld PJ
    Am J Ophthalmol; 2006 Jul; 142(1):141-3. PubMed ID: 16815262
    [No Abstract]   [Full Text] [Related]  

  • 3. Position paper: the need for head-to-head studies comparing Avastin versus Lucentis.
    Schmucker C; Antes G; Lelgemann M
    Surv Ophthalmol; 2009; 54(6):705-7. PubMed ID: 19818262
    [No Abstract]   [Full Text] [Related]  

  • 4. Avastin versus Lucentis: ethical issues.
    Wong HC
    Retina; 2008; 28(7):1024-5; author reply 1025. PubMed ID: 18698312
    [No Abstract]   [Full Text] [Related]  

  • 5. Avastin versus Lucentis: ethical issues in treatment of age-related macular degeneration.
    Klein RM; Klein RB
    Retina; 2007; 27(9):1163-5. PubMed ID: 18046218
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravitreal bevacizumab for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration.
    Bom Aggio F; Eid Farah M; Melo GB
    Acta Ophthalmol Scand; 2006 Oct; 84(5):713-4. PubMed ID: 16965511
    [No Abstract]   [Full Text] [Related]  

  • 7. Cheap shots and pricey propositions: evidence, disclosure, and treatment of age-related macular degeneration.
    Kimmelman J
    Retina; 2007; 27(9):1166-7. PubMed ID: 18046219
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravitreal bevacizumab for peripapillary classic subretinal neovascularization.
    Spandau UH; Jonas JB
    Acta Ophthalmol Scand; 2007 May; 85(3):340-1. PubMed ID: 17488467
    [No Abstract]   [Full Text] [Related]  

  • 9. Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks.
    Teixeira A; Moraes N; Farah ME; Bonomo PP
    Acta Ophthalmol Scand; 2006 Dec; 84(6):835-6. PubMed ID: 17083556
    [No Abstract]   [Full Text] [Related]  

  • 10. A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations.
    Algvere PV; Steén B; Seregard S; Kvanta A
    Acta Ophthalmol; 2008 Aug; 86(5):482-9. PubMed ID: 18162062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization.
    Zhu Q; Ziemssen F; Henke-Fahle S; Tatar O; Szurman P; Aisenbrey S; Schneiderhan-Marra N; Xu X; ; Grisanti S
    Ophthalmology; 2008 Oct; 115(10):1750-5, 1755.e1. PubMed ID: 18708261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value-based medicine.
    Kymes SM; Vollman D; Frick KD
    Ophthalmology; 2008 Nov; 115(11):2099; author reply 2100. PubMed ID: 19068385
    [No Abstract]   [Full Text] [Related]  

  • 13. Controversies in the treatment of wet age-related macular degeneration.
    Moreno SF; Paloma JB
    Am J Ophthalmol; 2008 May; 145(5):937; author reply 938. PubMed ID: 18435977
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration: a short-term study.
    Chen CY; Wong TY; Heriot WJ
    Am J Ophthalmol; 2007 Mar; 143(3):510-2. PubMed ID: 17317398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing ranibizumab with bevacizumab.
    Biswas P; Sengupta S; Choudhary R; Home S; Paul A; Sinha S
    Ophthalmology; 2011 Mar; 118(3):600-600.e2. PubMed ID: 21376243
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravitreal bevacizumab.
    Lucas RS; McKee HD; Lee LR
    Ophthalmology; 2007 Feb; 114(2):400; author reply 400-1. PubMed ID: 17270701
    [No Abstract]   [Full Text] [Related]  

  • 17. The as-needed treatment strategy for choroidal neovascularization: a feedback-based treatment system.
    Spaide RF
    Am J Ophthalmol; 2009 Jul; 148(1):1-3. PubMed ID: 19540983
    [No Abstract]   [Full Text] [Related]  

  • 18. Avastin and new treatments for AMD: where are we?
    Freeman WR; Falkenstein I
    Retina; 2006 Oct; 26(8):853-8. PubMed ID: 17031283
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
    Retina; 2007; 27(4):432-8. PubMed ID: 17420694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case of anterior uveitis after intravitreal injection of bevacizumab.
    Pieramici DJ; Avery RL; Castellarin AA; Nasir MA; Rabena M
    Retina; 2006 Sep; 26(7):841-2. PubMed ID: 16963867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.